Stupak will retire
This article was originally published in The Tan Sheet
House Oversight and Investigations Subcommittee Chairman Bart Stupak, an 18-year member of Congress and a frequent critic of FDA's record for food and drug safety, says he will not seek reelection. At an April 9 press conference at his congressional district in Michigan, the Democrat said he has served the public more than 30 years, beginning as a police officer in Escanaba, Mich., and later as a State Police trooper, before becoming a state representative and later a member of Congress. Like his recognized mentor, fellow Michigan Democrat John Dingell, Stupak said health care reform was a priority for him from the beginning, and stressed the significance of the recent passage of reform legislation (1"The Tan Sheet" March 29, 2010). "I've worked alongside my colleagues to achieve health care reform and I'm proud to have helped bring it across the finish line," he said, adding, "I felt that my main legislative goal was accomplished." Potential candidates have until May 11 to file to campaign for the office
You may also be interested in...
The health care reform law now enacted significantly restricts health savings and flexible spending account eligibility for OTC drugs, allowing reimbursement only of nonprescription drugs prescribed by a doctor
Senior executives from Bayer outlined at a recent summit the contours of digital transformation already underway and the vital components of a successful digital team. Firms need to be able to operate technology at the “speed of business” and not “at the speed of a ticketing queue.”
A Senate Health Committee update hearing on the COVID-19 federal response was noteworthy primarily for demonstrating that FDA Commissioner Stephen Hahn appears to have salvaged the agency’s position as a voice of credibility with a key political constituency – at least for now.